CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 
Lexaria Bioscience Corp.  (LXRP)
Other Ticker:  
 
    Sector  Consumer Non Cyclical    Industry Legal Marijuana
 
 
Price: $1.9800 $-0.04 -1.980%
Day's High: $ 2.09 Week Perf: -1.98 %
Day's Low: $ 1.94 30 Day Perf: 0.00
Volume (M): 199 52 Wk High: $ 2.54
Volume (M$): $ 394 52 Wk Avg: $ 1.43
Open: 2.05 52 Wk Low: 0.32
You need to upgrade your Flash Player


 Market Capitalization (Millions $) 141
 Shares Outstanding (Millions) 71
 Employees 4
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -6
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 0
Lexaria Bioscience Corp.
Our company’s business plan is currently focused on the development of strategic partnerships with licensees for our patented technology in exchange for up front and/or staged licensing fees over time. Secondarily and more generally, we continue to investigate national and international opportunities for development and distribution of the Company’s enhanced functional food and supplement product offerings; to investigate expansions and additions to our intellectual property portfolio; and, to search for additional opportunities in alternative health sectors. This includes the acquisition or development of intellectual property if and when we believe it advisable to do so. We announced issuance of our first patent by the U.S. Patent and Trademark Office (USPTO) on October 26, 2016 and have received a Notice of Acceptance from the Australian Patent Office with related patent issuance date June 15 2017 No. 2015274698. We announced on November 2, 2017 a new Notice of Allowance from the USPTO that included the delivery of additional molecules such as psychoactive cannabinoids, vitamins, non-steroidal anti-inflammatories, and nicotine all utilizing our DehydraTECHTM delivery technology. We are seeking additional patent protection for what we believe to be a unique process for the nutritional delivery of certain molecules such as cannabinoids, Nicotine, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), and Vitamins. To achieve sustainable and profitable growth, our company intends to control the timing and costs of our projects wherever possible.


LXRP is expected to report next financial results on October 12, 2018.
 

Lexaria Bioscience's Segments
 
 
  Company Estimates  
  Revenue Outlook
Lexaria Bioscience does not provide revenue guidance.

Earnings Outlook
Lexaria Bioscience Corp. does not provide earnings estimates.

 
Geographic Revenue Dispersion

Ccur Holdings, Inc.

Losses Widen,

For the forth quarter Ccur Holdings, Inc posted loss at $-0.18 per share, compare to results of $3.55 per share a year ago quarter, In the previous quarter company realized $-0.11 per share.

Hurco Companies Inc

Hurco Companies Inc announced third quarter operating profit of $9.361 millions

Hurco Companies Inc showed respectable growth in the third quarter, where earnings jumped by 63.79 % year on year to $0.95 per share and Sales increased by 29.59 % to $78.75 millions.

Culp Inc

Culp Inc announced first quarter operating surplus of $2.075 millions

In the first quarter Culp Inc eps dived by -80 % of $0.08 per share compare to $0.40 a year ago and eps dropped by -91.79 % from $0.97 per share from the previous quarter.

Sales declined in double digits by -10.13 % to $71.47 millions from $79.53 millions in the same quarter a year ago and sequentially Sales deteriorated by -8.58 % from $78.18 millions.

First Real Estate Investment Trust Of New Jersey

Despite Strong Sales Earnings Fell

Company's earnings deteriorated despite Sales growth in the third quarter, income fell sharply by -98.01 % to $0.04 per share, while Sales increased in double digits by 15.39 % to $14.63 millions, from the same quarter a year ago.

Five Below, Inc.

Five Below, Inc announced second quarter operating income of $30.422 millions

Five Below, Inc announced strong results in the second quarter, where Sales rose by 22.74 % to $347.73 millions and profits soared by 50 % to $0.45 per share, year on year.




LXRP's Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 110.13
Price to Sales (Expected) -
Price to Book 53.33
PEG (TTM) -
LXRP's Financial Strength Current
Quick Ratio 29.06
Working Capital Ratio 36.13
Leverage Ratio (MRQ) 0.03
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -
Per Share Current
Earnings (TTM) -0.09 $
Revenues (TTM) 0.02 $
Cash Flow (TTM) -0.01 $
Cash 0.03 $
Book Value 0.04 $
Dividend (TTM) 0 $

• View Valuation Comparisons • View Growth Rates Comparisons

You need to upgrade your Flash Player
LXRP's Efficiency Current
Revenue per Employee (TTM) 319,325
Net Income per Employee (TTM) -1,509,000
Receivable Turnover Ratio (TTM) 8.91
Inventory Turnover Ratio (TTM) 13.47
Asset Turnover Ratio (TTM) 0.48
LXRP's Profitability Ratio Current
Gross Margin 98.27 %
Operating Margin -
Net Margin -
Net Cash Flow Margin -
Effective Tax Rate (TTM) -
Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Payout Ratio (TTM) -
• View Efficiency Comparisons • View Profitability Comparisons • View Management Effectiveness


You need to upgrade your Flash Player

   
You need to upgrade your Flash Player
Major Competitors Stock performance

5 Days Decrease / Increase
     
• View Complete Report
   


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

IMN's Profile

Stock Price

IMN's Financials

Business Description

Fundamentals

Charts & Quotes

IMN's News

Suppliers

IMN's Competitors

Customers & Markets

Economic Indicators

IMN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071